OLA
PBH icon

Oliver Luxxe Assets’s Prestige Consumer Healthcare PBH Stock Holding History

Oliver Luxxe Assets’s Portfolio PBH Stock Details PBH Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q1 		– Sell
-13,519
Closed -$846K – 192
2022
Q4 		$846K Buy
13,519
+390
+3% +$22.4K 0.24% 92
2022
Q3 		$654K Buy
13,129
+341
+3% +$18.9K 0.2% 98
2022
Q2 		$752K Buy
12,788
+305
+2% +$16.8K 0.22% 100
2022
Q1 		$661K Buy
12,483
+2,665
+27% +$154K 0.17% 119
2021
Q4 		$595K Buy
+9,818
New +$583K 0.15% 120

Other funds holding PBH

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return
Macquarie Group
Macquarie Group Sydney, NSW 2000, Australia $16.8B AUM 27.39% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return
WHG
Westwood Holdings Group Dallas, Texas $13.7B AUM 21.48% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Massachusetts Financial Services
Massachusetts Financial Services Boston, Massachusetts $298B AUM 21.96% 1-Year Est. Return

Oliver Luxxe Assets's PBH Position: Q1 2023 in Review

Oliver Luxxe Assets sold out of Prestige Consumer Healthcare (PBH) in Q1 2023, closing a stake of 13,519 shares — an estimated $846K sold.

Oliver Luxxe Assets first reported a position in PBH in Q4 2021 and held it in 5 quarters. The position peaked at $846K in Q4 2022. 283 funds tracked by Wall St. Rank hold PBH as of Q1 2023.

  • Oliver Luxxe Assets reported no remaining Prestige Consumer Healthcare position as of Q1 2023 after selling out during the quarter.
  • Oliver Luxxe Assets sold 13,519 Prestige Consumer Healthcare shares in Q1 2023, an estimated $846K.
  • Oliver Luxxe Assets first reported a position in Prestige Consumer Healthcare in Q4 2021 and held it in 5 quarters.
  • Oliver Luxxe Assets's Prestige Consumer Healthcare position peaked at $846K in Q4 2022.
  • 283 funds tracked by Wall St. Rank held Prestige Consumer Healthcare as of Q1 2023.

Based on Oliver Luxxe Assets's 13F filing for Q1 2023, filed 19 Apr 2023.